Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Revenue: 2023-2024

Historic Revenue for Artiva Biotherapeutics (ARTV) over the last 1 years, with Mar 2024 value amounting to $251,000.

  • Artiva Biotherapeutics' Revenue was N/A to $251,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $30.2 million, marking a year-over-year change of. This contributed to the annual value of $251,000 for FY2024, which is 99.25% down from last year.
  • According to the latest figures from Q1 2024, Artiva Biotherapeutics' Revenue is $251,000, which was down 89.32% from $2.4 million recorded in Q4 2023.
  • In the past 5 years, Artiva Biotherapeutics' Revenue ranged from a high of $26.7 million in Q3 2023 and a low of $251,000 during Q1 2024.
  • Over the past 2 years, Artiva Biotherapeutics' median Revenue value was $1.7 million (recorded in 2023), while the average stood at $7.6 million.